Skip to main content


We are working on a new version of this page and we'd like your opinion. See an early preview or learn more.

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial

  • David A Palma1Email author,
  • Cornelis J A Haasbeek2,
  • George B Rodrigues1,
  • Max Dahele2,
  • Michael Lock1,
  • Brian Yaremko1,
  • Robert Olson3,
  • Mitchell Liu3,
  • Jason Panarotto4,
  • GwendolynHMJ Griffioen2,
  • Stewart Gaede1,
  • Ben Slotman2 and
  • Suresh Senan2
BMC Cancer201212:305

Received: 18 April 2012

Accepted: 23 July 2012

Published: 23 July 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
18 Apr 2012 Submitted Original manuscript
26 Apr 2012 Author responded Author comments - David Palma
Resubmission - Version 2
26 Apr 2012 Submitted Manuscript version 2
17 Jun 2012 Reviewed Reviewer Report - Dirk Vordermark
Resubmission - Version 3
Submitted Manuscript version 3
23 Jul 2012 Editorially accepted
23 Jul 2012 Article published 10.1186/1471-2407-12-305

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Department of Radiation Oncology, London Regional Cancer Program
Department of Radiation Oncology, VU University Medical Center
Department of Radiation Oncology, British Columbia Cancer Agency
Department of Radiation Oncology, Ottawa Regional Cancer Centre